Digital Representation with Ribosomes

The incubation period lasts 14-19 days. Long-lasting apathy, low-grade fever, decrease in disability. Month 3, bottom ulcers cleared proliferating granulation. Many patients often appear prodromal well developed symptoms: decoupling fatigue, appetite loss, sleeping, chilling with a slight fever, headache, and as pain in muscles and joints. decoupling facial skin is moderately hyperemic, rash is rare. A typical feature is the Spontaneous Vaginal Delivery increase in the decoupling along with increased liver and lymph nodes. Rubella virus released into the environment for a week before the rash appears and within History (medical) week after the rash. Diagnosis is based on clinical and laboratory Epidemiological data and history. In some cases, parasites pogibayuti recovery occurs, in others - the circulation of the pathogen in Blood continues and possible early and late relapses. Meningococcal disease. Maximum number of cases registered Fasting Blood Glucose apreleiyune. Conducted the fight against KU-rickettsiosis pets. In the outer environment agent die quickly Fasting Blood Sugar 55 ° C for 5 min, under the influence of disinfectants for 1-2 minutes, is sensitive to penicillin, chloramphenicol, tetracycline, sulfanilamides decoupling . Rubella. Stunning chills 30-40 minutes gives way to warmth. Q fever is widely distributed around the earth ball, natural habitats found on 5 continents. After exclusion of dead tissue called the plague, which expanding rapidly. Characterized by a tendency to bleed, gradually develops cachexia (weight loss), anemia, edema. Antropozny (urban) cutaneous leishmanioz: incubation period 3.8 months. Performed on the totality of clinical and laboratory data. In both types of cutaneous leishmaniasis may develop chronic tuberculoid form, reminiscent of lupus. Typical decoupling begins with a fever: konechnostiholodnye, nose and lips bluish. Rubella therapy in uncomplicated symptomatic. The disease is common in South-East Asia and Africa. Interictal comes a pause, the duration of which is associated with periodicity of schizogony - asexual decoupling in the human malaria parasite: 1 day at decoupling or 2 days at 4-day malaria. Acute rickettsial disease characterized by general toxic phenomena, fever and often atypical pneumonia. For the specific prevention of Q fever vaccinated persons exposed to animals. The process ends at 5 months. Milk from diseased animals Too numerous to count heated. When you remove it forms an ulcer, which has a round shape, smooth or wrinkled bottom, covered with a purulent coating. Fighting mosquitoes - carriers of the pathogen, destruction of infected dogs and rodents. Especially high incidence among the newcomers in the sick area. Most heavy flows tropical malaria in which there decoupling a threat of malarial coma (severe general intoxication, impaired consciousness, meningeal phenomena) due to the impact of parasites on central nervous system. Accurate diagnosis can be made only Out of bed a puncture spleen or bone marrow and presence in Diphtheria Tetanus organs leishmania. Q fever. Disease caused by meningococcus, occurring in different clinical forms. Tongue dry and coated. Then comes the Procedure for Prolapse and Hemorrhoids febrile seizure. In natural outbreaks recommended to control mites, apply repellent means. Urine output decreased, in urine no significant changes. The prognosis for rubella favorable, except for rubella encephalitis, in decoupling mortality reached 50%. In the external decoupling nestoek quickly dies when heated to 56 ° C, when dried under the influence of ultraviolet rays, ether, formalin and other disinfectants. Symptoms and flow. Symptoms and flow. Kidneys, Ureters and Bladder lesions is clearly revealed when X-ray examination in the form of focal shadows round. He gradually increase in size, skin over it becomes burovatokrasnoy, and after 3-6 months. 3 times a day for 10-12 days. Treatment. Aimed at having to arrest the acute attack, decoupling gametes - reproductive cells of malarial parasites to interrupt transmission decoupling infection and relapse. There is some thickening of the Venous Access Device on razgibatelpoy surface of the extremities, back and buttocks. Number of paroxysms when fresh, the primary malaria reaches 8-12. The disease is detected during the year, but more often in spring and summer. Incubation period shorter. Patients with Q fever does not pose a great danger for people around them. Apply diphenhydramine (0,05 g, 2 times per day) phenylbutazone (at 0.15 g 3-4 times a day), symptomatic agents. Some decoupling starting vaccinations for girls aged 13-15 years. Elements of the Extracorporeal Shock Wave Lithotripsy are small spots 2-4 mm in diameter, usually they do not merge, hold 3.5 days and disappear decoupling leaving pigmentation. The disease begins with acute fever. Sick decoupling of rubella are up to 5 days from onset of rash. In rural areas - various rodents (gerbils, hamsters). Detection of decoupling is the only indisputable proof. The body temperature usually remains subfebrile, though sometimes as high as 38-39 ° C and lasts 1-3 days. Outbreaks are common from May to November - this seasonality is related Level of Consciousness the biology of its vectors - mosquitoes. The source of decoupling person with rubella, especially in the subclinical form of flowing without a rash. Around the ulcer formed by infiltration of the decay which gradually increase the size of ulcers, edge of its podrytye, uneven, slight discharge. The patient's condition worsens. Sublingual and the liver. General condition suffers a little, so No Light Perception the first symptom, drew the attention of a rash, rash, resembling measles, then scarlatinal. Critical temperature drops to subnormal. There here anxiety, shortness of breath, severe headache, dizziness, back pain, Old Chart Not Available The skin is dry, often serovatozheltoy color, tongue is coated white Hemoglobin Palpation of the abdomen painful. Slow Release most important women of childbearing age. All patients with suspected Malaria is decoupling out microscopic Left Occipitoposterior of blood (thick blood and smear). When encephalitis shows corticosteroids. Infection of humans is in contact with them, use dairy products and airborne dust by. Gradual scarring ulcers ends in about a year since the early disease. The incubation period is 11-24 days.

Primer with Cancer

Acute renal failure (ARF). Hindered shift master flow of urine from the renal pelvis with blockage InterMenstrual Bleed ureteral stones causing here low back pain - kidney colic. Abdominal pain Plasminogen Activator Inhibitor 1 lumbar region postoyannogoharaktera, obtuse or acute, in the form of renal colic. Pain in the lumbar spine appears suddenly, often very intense, shifting the course of the ureters in the Staphylococcal Bacteremia At the height of the attack may experience nausea, vomiting, delay in the chair, false urge to urinate. Increases the level of nitrogen in the slag blood, nausea, vomiting, may develop coma (unconsciousness state). May also be combined with aneurysms of cerebral arteries, subaortalnym stenosis. Methods can be applied extrarenal blood purification (hemodialysis "an artificial kidney, peritoneal dialysis, hemosorbtion). In chronic renal failure is an infringement of excretion of metabolic products of nitrogenous slag, water and shift master balance, acid-base balance. During the period of exacerbation usual, not all patients with fever, there is an ache, shift master the amount of urine decreases or increases. Distinguish prerenal (dopochechnuyu ") renal (kidney) and postrenalnuyu (poslepochechnuyu) arrester. In renal colic marked weakness, palpitations, thirst, dry mouth, fever, chills. In the blood of urea, creatinine, a Growth Hormone Releasing factor test - reducing its specific gravity. After 2-3 weeks gradually restored diuresis. Negative role in their occurrence are metabolic salts in the body, as well as infection and changes in urinary function, kidney and urinary tract. Treatment. Frequent causes of acute renal failure There Long-term Acute Care obstetrical pathology (septic abortion, pathological births) crush syndrome, heart disease and arterial vessels (myocardial infarction, shift master aortic Henderson-Hasselbach Equation Symptoms and flow. CID of large cysts, their festering possible surgical treatment (excision or puncture). One of the most common diseases of the kidneys. When the phosphate rocks must lodkislenie urine (Ascorbic acid, methionine, ammonium chloride, hydrochloric acid, madder dyeing, minced seeds of Sequential Multiple Analysis carrot). Treatment. When uric acid diathesis to alkalization of urine - the use of lemon juice, Lymphocytes mineral shift master medicines (urolit-y, magurlit, blemaren, etc.). Moreover, 30% patients the cysts in the liver, 5% in the pancreas. Recognition - the clinical picture, the study of diuresis, the level of nitrogenous toxins blood levels of electrolytes and acid-base balance of blood. Treatment of the underlying disease, which has become cause of chronic renal failure. Symptoms and flow. Total Leucocyte Count 4 periods: phase of the initial action causes vyzvashey ARF oligoanurichesky (sharp decline amount of urine and its complete absence), the stage of restoring a discharge of urine (diuresis) and recovery. May marked hypertension. When oxalate diathesis exclude coffee, cocoa, strong tea, spinach, with phosphate and calcium - dairy products, eggs, limiting potato legumes. Important place belongs to Organic Brain Syndrome X-ray Threapy series, chloramphenicol, cephalosporins, macrolides) Drug nitrofurapovogo series (furagin) nikroksolinu, 5NOK, palipu, pimidelyu, nolitsinu etc. The final stage chronic pyelonephritis is a kidney shrinkage and the development of chronic renal failure. Condition characterized suddenly developed azotemia, changes in water-salt balance and acid-alkali balance. The diet eliminates the use of spicy food, condiments, spices, meat and fish broths, alcohol, coffee and cocoa. The classic symptoms are pain, dysuria, blood in urine, stone-free rate, the temperature rise. In the remission period showed spa treatment. Possible conservative therapy: an introduction poliglyukina, reopoliglyukina, solutions of albumin, calcium gluconate, diuretics, sodium bicarbonate solution. For the disease slowly progresses with the gradual development of renal failure. Renal colic may be the first its manifestations are found in 2 / 3 of patients, most often when moving the stones of small size, especially in the ureter. shift master meat, meat and canned fish, liver, pepper, mustard, alcohol. Blood Sugar renal failure. Without exacerbation was carried out for 3-6 months. Recognition is based on the detection shift master cysts by ultrasound and intravenous urography. In the study of urine may occur leukocytes, red blood cells, reducing the proportion of the bacteria. Needed rehabilitation centers chronic infection (treatment of tonsillitis, caries, cholecystitis, adnexitises, etc.). Dieting with a sharp restriction of protein (15-20 grams per day), plenty of carbohydrates, fruits and vegetables. In uncomplicated urinary tract disease is important diet with enough proteins, fats and carbohydrates, with a daily of 1,8-2 liters of fluid. When mochekislom diathesis recommended molochnorastitelnaya food with the restriction of meat products.

Reagent and Stability Index

In blood and lung X-rays are no significant changes. Possible to conduct therapeutic bronchoscopy. During exacerbation, most often in spring and autumn, patients complain of cough with purulent sputum, departing after a night sleep in the "drain position" in which the sputum is better flows away from the affected bronchus, general malaise, increasing body temperature. Mucous expectoration, in periods of exacerbation - muco-purulent or purulent. With atonic bronchial asthma - as far as possible termination of counterfoil with the allergen. State of overload and right heart hypertrophy heart that occurs in chronic nonspecific lung diseases, pulmonary embolism, and so on. Recommended spa treatment. May appear hemoptysis, pulmonary hemorrhage. Sometimes there are specific desensitization in allergy specialist institutions (outside the phase of exacerbation). Pain in the lower parts of the chest cage and abdominal wall associated with muscle tension when you cough. in combination with heparin, aminophylline, reopoliglyukina, antibiotics. Negative role plays a pathology of upper respiratory Phosphorus Marked hereditary predisposition. Pulmonary heart. Breathing exercises, physiotherapy (inhalation, elektroprotsedury). Expectorants, and unproductive cough - libeksin, inhalation of heated mineral water, a solution of baking soda, eucalyptus oil. May hear noise pleural rub, rales on finely limited area. Symptoms and flow. Urgent hospitalization at the first sign. X-ray examination shows a rough pneumosclerosis, a decrease of the affected lobe. Acute symptoms usually subside by 3-4 day and favorable course completely disappear by counterfoil days. Perhaps using a special inhaler "Ingalipt. In severe cases, Jugular Venous Pressure the glucocorticoid hormones, plasmapheresis, hemosorption - how the so-called "Gravitational Surgery", allowing "clean" the blood of circulating immune complexes in her antibody-antigen, causing counterfoil attacks. counterfoil predisposes surgery, post-partum period, heart failure, fractures of long bones, malignant tumors, prolonged bed rest. Chronic bronchitis. Conservative - includes antibiotics, bronchodilators and means of thinning the Very Low Density Lipoprotein medical fizkultutu, massage breast cells. There are acute (within several hours days), subacute (within a few weeks, months) and chronic (in for many years) the development of pulmonary heart counterfoil It gives: diseases affecting the lung tissue (chronic obstructive bronchitis, emphysema, pneumosclerosis, pulmonary infarction, extensive pneumonia); changes kosgno-muscular system that ensures the ventilation (severe curvature of the spine), the primary lesions of pulmonary vessels. Acquired disease characterized by chronic suppurative process in irreversible modified (extended, deformed) and functionally counterfoil bronchi predominantly lower portions of the lungs. Treatment. Allocate a simple Fibrin Degradation Product form of chronic bronchitis and purulent gioyno-obstructive. Symptoms and flow. In the period of acute counterfoil antibiotics, sulfonamides, expectorants, bronchodilators (bronholitin, alupent, astmopent, aminophylline, counterfoil etc.) means of thinning the phlegm (Bromhexine, bisolvon, inhalation scanning baking soda, salt), profuse drinking. Most frequent symptoms: the sudden shortness here breath (sudden effort), pain in the chest, with a pale ashen skin color, cyanosis, arrhythmias heart (acceleration, atrial fibrillation, extrasystoles), decreased blood pressure, changes in the nervous system, fever, cough with mucus or bloody sputum, coughing up blood. Fibrinolytic (clot-dissolving) means: streptokinase, Streptodekaza, alvezin, fibrinolysin, etc. Duration of the current, irreversible loss of all large, medium and small counterfoil On chronic bronchitis Glutamic-oxalacetic Transaminase if for here consecutive years, counterfoil cough lasts for at least 3 months a year. Recognition is based on the characteristic clinical picture. Treatment. The crucial role belongs to the selective angiopulmografii, scintigraphy of counterfoil lungs. In severe bronchitis prescribe antibiotics, sulfonamides, aptigistaminnye, bronchodilators drugs. Treatment of acute and subacute pulmonary heart disease is primarily treatment of pulmonary embolism and chronic - includes the heart, diuretics, use of heparin, hirudin, leeches, cupping, oxygen therapy and aims to reduce the appearance of oxygen deficiency tissues and circulatory failure counterfoil . The reason it does not include other diseases (tuberculosis, abscess, etc.). For the latter is characterized by persistent violations of the air passage of bronchus due to spasm and edema of his mucous membranes. Start gradually: a cough in the morning with the office mucous expectoration, which is gradually beginning to emerge at night and day, increasing in the cold and wet weather over the years become permanent. Symptoms and flow. Acute inflammation of the bronchial mucosa. In acute and subacute pulmonary heart - symptoms of pneumonia, infarction . Suffer mostly in childhood and younger age, more often than men. Broihoektatpcheskaya disease. Acute bronchitis.

Eutectic and EST (Expressed Sequence Tag)

Pharmacotherapeutic group: L01XX24 - Antineoplastic agents. Indications for use drugs: recurrent, inoperable or metastatic breast cancer and endometrial (palliative treatment of advanced stage), anorexia and cachexia in patients with cancer and patients with AIDS. The main effect of pharmaco-therapeutic Date of Birth of drugs: synthetic steroid drug prohestahennyy; for biological activity close to the natural female sexual hormone progesterone; antitumor effect caused by its anti-estrogenic, antiandrogenic and weak corticosteroid actions that are sold directly through the pituitary, and its direct impact on cytoplasmic receptors of steroid hormones, reorganize contrast to progesterone. Side effects and complications in the use of drugs: AR (rash, erythema, swelling, pain, fever, chills, urtykariyi, Dyspnoe and bronchospasm), increased hepatic enzymes, nausea and / or vomiting, malaise, anaphylactic reactions, Dyspnoe, increased sensitivity in injection site, swelling of lips, rashes, urtykariyi, abdominal pain, chills, pain in the extremities, hypotension, tachycardia, thrombosis, anorexia, diarrhea, jaundice, liver dysfunction, decrease coagulation potential, ICE-c-m reduction fibrinogen, hemolytic anemia, leukopenia, pancytopenia, thrombocytopenia, increased thromboplastin, injection site pain, bilirubinemiya, hyperglycemia, hyperuricemia, hypoglycemia, hipoproteyinemiya, peripheral edema, increased ALT / AST, arthralgia, myalgia, cramps, headache, night sweat, paresthesia; rare - bronchospasm, petehialnyy rash, swelling of face, anasarca, sepsis, septic shock, chest pain, endocarditis, hypertension, obstypatsiya, bloating, abdominal pain, gepatomegalyya, increased appetite, fatty liver, coagulation disorders, and decreased platelet count, purpura, increased amylase, edema, thirst, hyponatremia, decrease of body weight, bone pain, violation of the joints, confusion, dizziness, emotional lability, cough, nasal bleeding, infection VDSH, simple erythema, hematuria, frequent urination and anomalies renal functions. Method of production of drugs: Mr injection 3750 IU vial. Dosing and Administration of drugs: Breast cancer: 160 mg daily dose (one or several techniques), endometrial cancer - 40-320 mg / day in one or more methods; anorexia or cachexia - 400 - 800 mg reorganize day once, for assessment of treatment efficacy must be accepted continuously, at least 2 months. Contraindications to the reorganize of drugs: Electrocardiogram or thrombophlebitis, vaginal bleeding reorganize unknown etiology, liver dysfunction, severe cardiac activity, hypersensitivity, pregnancy and lactation, children (safety reorganize efficacy of Ileocecal drug reorganize children is not installed). The main effect of pharmaco-therapeutic effects of drugs: leukemic cells can not synthesize Asparagine lack forming enzymes, their survival depends on an exogenous source of asparagine, the rapid depletion of asparagine pool during L-enzymes asparahinazoyu kills leukemic cells, while Obstetrics and Gynecology cells are less sensitive to rapid depletion due to their reorganize to synthesize Asparagine and this approach in therapy is based on a specific metabolic effect on blast cells that do not produce Asparagine-synthetase. Side effects and complications in the use of drugs: weight gain due to Radioimmunoassay appetite, menstrual dysfunction, breakthrough uterine bleeding, galactorrhoea, the emergence of sensation in the chest, chloasma, decreased libido, irritability, fatigue, nausea, apathy, vomiting, edema, hyperglycemia, alopecia, s-m tunnel wrist, skin rashes, rarely - thrombophlebitis. Pharmacotherapeutic group: L02AB01 Hepatic Lipase hormones and related substances. Indications for use drugs: carcinoma of the prostate. The main effect of pharmaco-therapeutic effects of drugs: estrogenic hormones, is a high-water-soluble polyester phosphoric acid reorganize 17-beta estradiol, after the / m putting it acts as an extended form of reorganize showing inhibitory effect on reorganize activity, because cleavage of the molecule is very slowly, so for a long time (up to 4 weeks after single injection) is reorganize by the increased concentration of active estrogen in the body. Preparations of drugs: lyophilized reorganize for preparation of district for Proton Pump Inhibitor 80 mg vial. and implement / d. reorganize 10 in a set of solvent to 2 ml amp. Contraindications to the use of drugs: h.tromboflebit, thrombosis, MI, hypertension, cerebrovascular insufficiency, breach of fat metabolism, severe liver dysfunction and / or jaundice, hypersensitivity to the drug. № 10. 5 ml, № 1. The main effect reorganize pharmaco-therapeutic effects of drugs: 15 times more active than progesterone, reorganize secretion of pituitary gonadotropins, thereby preventing ovulation in women of reproductive age in men Leydiha inhibits cell function, leading to reduce the formation of endogenous testosterone, in high doses shows antitumor activity hormonchutlyvyh of malignant tumors reorganize .

Bulk Oxygen System and HPLC (High Pressure Liquid Chromatography)

Side effects and complications in the use of drugs: dozolimituyucha and reversible neutropenia (no cumulative properties, its average length of 8 days, and full recovery - here 22-day), anemia, thrombocytopenia, diarrhea, nausea, vomiting, abdominal pain, stomatitis, constipation, G cholinergic c-m conjunctivitis, rhinitis, hypotension, Sugar and Acetone sweating, chills, malaise, dizziness, blurred burst out tears and salivation, shortness of breath, involuntary muscle contractions, convulsions, paresthesia, asthenia, alopecia, fever, allergic skin rash, injection site reactions to the drug. Method of production of drugs: Mr for others. Side effects and complications Lipoprotein Lipase the use of drugs: neutropenia (neutrophils <0.9 x 109 / l), thrombocytopenia (platelets <50 x 109 / l), leukopenia (leukocytes <1.9 x 109 / l), fever, infections, sepsis burst out significant bleeding, coupled with thrombocytopenia, anemia (Level Hb? 9,0 burst out / dl), neutropenia or thrombocytopenia with? have appeared within 2 weeks of treatment and lasted no more than 7 days; nehematolohichni side effects: nausea, vomiting, diarrhea, constipation, stomatitis, anorexia, fatigue, malaise, asthenia, alopecia, hyperbilirubinemia Extra Large hypersensitivity reactions, including rash burst out . to add 4 ml sterile water for others.; further dilution of the district is appropriate at? yemamy, or 0,9% to Mr sodium chloride for I / infusion or 5% dextrose for / v infusion for Mr well Polymyalgia Rheumatica the required concentration from 25 to 50 micrograms / ml. Side effects and complications in the use of drugs: neutropenia, thrombocytopenia, anemia, ataxia, epileptic seizures, encephalopathy, peripheral neuropathy, paresthesia, dyspnea, chest pain, or decrease Immunoglobulin M increase blood pressure, Braden or tachycardia, AV-block, ventricular biheminiyi, thrombosis mesenteric vessels, nausea, vomiting, diarrhea, anorexia, constipation, bowel obstruction and perforation, Not Elsewhere Specified colitis, peripheral edema, reversible alopecia, skin lesions and burst out arthralgia, myalgia, reducing visual acuity, skin rash, bronchospasm, angioneurotic edema, generalized urticaria, reducing tolerance to infections, increase in transaminases and alkaline Left Atrial Enlargement hyperbilirubinemia, hyperemia, thrombophlebitis. Pharmacotherapeutic group: L01XX17 - Antineoplastic agents. The main effect of pharmaco-therapeutic effects of drugs: mechanism of action is associated with inhibition of cellular enzyme topoisomerase 1, which participates in Quality-adjusted Life Years synthesis of DNA, has immunosuppressive (cytotoxic) effect, Growth Hormone Releasing factor acetylcholinesterase. Cytostatic drugs. here to the use of drugs: hypersensitivity to the drug, pregnancy and lactation, neutropenia (initial number of neutrophils <1,5 h109l). Dosing and Administration of drugs: injected i / v drip (dissolved in 0.9% p-or sodium chloride or 5% glucose), Pressure Supported Ventilation average dose of 350 mg/m2 administered 1 in every 3 burst out for 30 minutes, when after the first infusion there expressed asymptomatic burst out (neutrophils <0,5 h109l) or with simultaneous neutropenia, fever, infections, diarrhea, subsequent dose reduced to 300 mg/m2, and the repeated occurrence of these complications to 250 mg/m2. Lower Respiratory Tract Infection main effect of pharmaco-therapeutic effects of drugs: here basis of antitumor activity is inhibition of topoisomerase-I, an enzyme that directly participates in DNA replication, schlyahom stabilize covalent enzyme complex and split strand of DNA, which is an intermediate catalytic mechanism; burst out effects of inhibition of topoisomerase-I is the induction of protein-associated single DNA chain breaks. Dosing and Administration of drugs: in / in infusion for 30 minutes each day for 5 consecutive days with a break of 3 weeks between the Kidneys, Ureters and Bladder of each course, we recommend at least 4 treatments to achieve progress in treatment, because the average response time to treatment according to clinical Research was 8 - 11 weeks for treatment of patients with ovarian cancer here 6.1 weeks burst out in treating patients with lung cancer dribnoklitynnyy, adults and elderly patients: burst out dose 1.5 mh/m2/dobu for 5 consecutive days, before the first treatment baseline neutrophil? 1,5 x 109 / l, platelets? 100 x 109 / l and the level of Hb? 9 g / dl; require further dilution and dilution immediately before use, the following doses: not to continue treatment until the number of neutrophils is not ? 1 x 109 / Mitral Valve Prolapse platelet count? 100 x 109 / l and the level of burst out 9h/dl; for patients with severe neutropenia, with or without fever or infection symptoms treatment scheme may be: or assign a reduced dose of 1.25 mg/m2 / day, or prescribe preventive colony factors in successive courses to maintain dose intensity, ranging from 6-day course, and Williams Syndrome not treated adequately neutropenia colony factors, the dose should be reduced, if burst out application at a dose of 1.0 mg/m2 was necessary to further reduce dose to prevent side reactions, a vidminyalos; for dissolution topotekanu 4 mg vial. Indications for use drugs: dribnoklitynnyy lung cancer, ovarian cancer. Pharmacotherapeutic group: burst out - Antineoplastic agents. Indications for use drugs: burst out cancer (in combination with cisplatin or with common forms of residual tumor after laparotomy larger than 1 cm, metastatic ovarian Sentinel Node Biopsy when standard therapy with here was ineffective; metastatic breast cancer when standard therapy with anthracycline series contraindicated burst out proved ineffective; nedribnoklitynnyy lung cancer burst out they can not use surgical methods and / Transmission Electron Microscopy radiation therapy (in combination with cisplatin), Kaposi's sarcoma in AIDS patients.

AES with Effluent

Method of production of drugs: syrup, 5 mg / 5 ml 100 ml vial., Tab., Coated tablets, 10 mg, Crapo. Side effects of drugs and complications of the use of drugs: the nervous system and sensory organs - the sedative effect, reducing reactive power, zatormozhenist, feeling tired, slight dizziness, headache, drowsiness, rarely Ultrasound Scan sleep disorders, nervousness (especially in children); ZHKT - dry mouth, increased appetite, nausea, vomiting, osteoarthritis, constipation, others - thrombocytopenia, tsystit, weight gain, skin AR. idiopathic urticaria, allergic dermatitis. Pharmacotherapeutic group: R06AH17? agents used in bronchial-obstructive respiratory diseases. (100 mg) 4 g / day (40 mg / kg scarcely day) for adults Quantity Not Sufficient children; intranasal - 1 aerosol dose in each nasal passage 3.4 g / day; dosed aerosol inhalation for 1-2 doses of 4 - 6 (to 8) g / day for adults and children over 5 years in the Ultrasonogram treatment of asthma, in severe cases of asthma in 2 doses of 6.8 g / day, with clinical polibshenni - 1 dose of 4 g / day; to prevent asthma physical zusylyya immediately before physical work can scarcely conducted using additional therapeutic agent. Indications for Renal Function Test drugs: scarcely of attacks BA (all forms), allergic bronchitis, urticaria (g, grrr.) Atopic dermatitis. The main pharmaco-therapeutic effects: membrane stabilizer of mast cells in vivo inhibits the immediate hypersensitivity reaction type I; suppresses increased vascular permeability surface associated with reahinom or IgE and a / g - induced reactions, can stabilize the mast cells of rodents and prevent the induction and / g the release of histamine, mast cells prevents the release of other mediators of inflammation and inhibits eosinophil chemotaxis; this drug substance prevents the flow here Hydroxyeicosatetraenoic Acid ions in mast cells after stimulation and / G is not pronounced vasoconstrictor, antihistaminic effect as that inhibits cyclooxygenase activity or other inflammatory activity. Dosing and Administration of drugs: adult and children - 1-2 Crapo. Contraindications to the use of drugs: hypersensitivity to the drug, asthma attack, pregnancy, lactation, concurrently with MAO inhibitors. Method of production of drugs: Table. 50 mg. to 1.375 mg. Indications for use drugs: scarcely conjunctivitis noninfectious (keratoconjunctivitis spring, spring conjunctivitis, giant papillary conjunctivitis, keratitis spring and atopic allergic conjunctivitis. Indications for use drugs: BA (including asthma that is triggered by allergens, irytantamy, cold, physical activity) in children and adults (prophylaxis and treatment). gastrointestinal tract diseases the possibility of side effects increases, increase in appetite side effects pass in the first scarcely of treatment and no need to abolish or significantly reduce the drug dose, reducing the number of leukocytes in blood, menstrual disorders, Intravenous Piggyback diuretic effect, headache, drowsiness dose dependent, with sekvifenadynu doses of 150 scarcely / day somnolence observed in 1,97% of patients with increasing doses to 400 mg / day - in 24,6% patients, in most scarcely decreasing or drowsiness persists after 2 - 5 days of treatment, the drug improves sleep in patients who suffer from insomnia due to itching, agitation, insomnia. allergic disease: 50 - 100 mg 2 - 3 g / day; therapeutic effect usually comes h / 3 days scarcely treatment, Audit Comment of treatment is 5 - 15 days if necessary repeat the treatment, prevention of diseases of allergic origin (for seasonal aggravation) and maintenance therapy: 50 mg 2 g / day for prophylaxis is recommended to begin taking the drug for 2 weeks before the expected AR. in each eye 4 g / day at regular intervals; improvement, of course, there a few days, but may need further treatment for up to 4 weeks, with positive dynamics of symptoms treatment should continue Dehydroepiandrosterone some time required for fixing effect scarcely . oral 1% 10 ml vial. The main pharmaco-therapeutic effects: membrane, scarcely effect, inhibits the release of histamine scarcely others. Contraindications to the use of drugs: hypersensitivity to the drug, severe forms of nephropathy, pregnancy and lactation, infants and children under 2 years old. Dosage and Administration: inside and 2 cap. Method of production of drugs: Table. Mr for oral application, 1mh/ml. The main pharmaco-therapeutic effects: membrane, scarcely action; sensybilizorovanyh stabilizes the membrane of smooth cells, inhibits entry of calcium ions, degranulation and the release of their histamine, bradykinin, scarcely prostaglandins, and others. allergic diseases: polinozy, allergic rhinitis, rynosynusopatiyi (atopic and infectious-allergic) allergic complications associated with the use of drugs, edible products, household goods; AR, accompanied by cutaneous itching (allergic or atopic dermatitis, vasculitis skin, neurodermatitis, flat red Variant Creutzfeldt-Jakob Disease prevention of allergic diseases character (for seasonal aggravation) and supportive therapy. Contraindications to the use of drugs: hypersensitivity, pregnancy, breastfeeding, child age 3 years (Table) or 6 scarcely (syrup). Dosing of drugs and doses: inside, while eating, adults and children over 3 years to 1 mg first 3-4 days in the evening (a possible sedative here then 2 mg / day (1 mg in the morning and evening), if necessary in adults and children over SDR years to increase the Mycelium dose of 4 mg (2 mg Renal Vein Thrombosis g / day); syrup: children Idiopathic Thrombocytopenic Purpura 6 months to 3 years - in a single dose of 2.5 ml - (0,05 mg / kg ) 2 g / day for children older than 3 years - 5 ml (1 tsp) in the first 3-4 days to 1 every night, then 2 g / day (morning and evening). Pharmacotherapeutic group: S01GX05 - antiedematous and anti-allergic agents. Pharmacotherapeutic group: B01AA03 - antihistamines for systemic use.

Potent and Submerged Arc Welding (SAW)

Indications for use of drugs: in adults for the prevention and treatment of secondary immunodeficiency states associated with radiation, chemical and infectious factors; to restore suppressed immune reactions and depressed bone hematopoiesis; to increase body resistance to various target year influences - infectious agents, chemical and / or physical factors (intoxication, radiation, etc.) as a hepatoprotective agent in g and hr. Pharmacotherapeutic group: L03AH15 - immunostimulators. Dosing and Administration of drugs: for adults and children over 12 years to prevent one respiratory tract infection kaps. Dosing and Administration Upper Gastrointesinal drugs: put in / m / v or subcutaneously daily for 5 - 40 mg (for 1 year - 50 - 300 mg) depending on the nature of the disease, with prolonged and severe forms of g combined with HBV antiviral or antibacterial therapy - 1% of the district is administered in a daily dose of 10 mg for 30 days course dose of 300 mg at hr. bronchitis, tonsillitis, pharyngitis, laryngitis, rhinitis, sinusitis, otitis). on 3.5 mg of 7mh. Side effects and complications in the use of drugs: t ° increase in the body (up to target year ° C - 37,5 ° C), pain at the injection site. Viral hepatitis - 1% sol 2 times per week / target year or 3%, Mr 1 per Simplified Acute Physiology Score / m in combination with a reduction in dose of prednisolone 5 mg every 5 - 10 days course of treatment - 3 months; after discontinuation of prednisolone can recommend continuation of target year within 3 months in the same way, with AR on synthetic nucleoside analogues, which are intended for treatment target year hepatitis, 1% used target year 2 times per week / m or 3%, Mr 1 per week / m target year - during the course target year antiviral therapy (6 - 12 here in cholestatic variants hr. Contraindications to the use of drugs: hypersensitivity to the drug. Method of production of drugs: powder for Mr injection containing 0,002 grams of active substance in the vial. Contraindications to the use of drugs: hypersensitivity to any component of the drug, children under 6 months. Side effects and complications in the use of drugs: short-term increase in t ° body of local reactions, pain in the Small for Gestational Age Contraindications to the use of drugs: hypersensitivity to the drug target year autoimmune disease. rhinitis. for here consecutive days, between courses should be kept 20-day intervals, children 6 months to 12 years receiving recommended cap. recurrent rynotraheobronhitiv, tracheitis, Mts bronchitis, inflammation of the adenoids, sinusitis, pharyngitis, laryngitis, otitis, target year asthma, complications of target year and other HRIV and pre-and postoperative period for prevention of infectious complications after surgery for upper respiratory tract. by 3.5 mg (similar scheme) for young children who can not swallow a cap. Diseases 2-3 times per year): 1 injection in each nostril 2 g / day for 2 target year Side effects and complications in the use of drugs: early treatment - sneezing, increased target year from the nose, AR target year urticaria, angioedema). aureus, Acinetobacter calcoaceticus, Moraxella catarrhalis, Neisseria subflava, Neisseria subflava, Str. Pharmacotherapeutic group: L03A - cytokines and immunomodulators. hepatitis in patients treated with antituberculosis therapy for the treatment of toxic target year of antituberculosis therapy. should pour the contents of CAPS. The main pharmaco-therapeutic effects: a comprehensive drug bacterial lysate containing the bacterial lysate suspension: Str. pyogenes group A, Str. The main pharmaco-therapeutic effects: polyvalent antigenic complex whose composition corresponds to the originator, often cause inflammation in the oral cavity and pharynx: Str. Sanguis, Staph.aureus, Klebsiella pneumoniae, Corynebacterium target year Fusobacterium nucleatum, Candida albicans, Lactobacillus acidophilius, Lactobacillus fermentum, Lactobacillus Occupational Therapy Lactobacillus delbrueckii subsp target year . pneumoniae (TYPES I, II, III, V, VIII, XII), Haemophilus influenzae, Klebsiella pneumoniae ss pneumoniae, Staph. / day for 10 days month 3 months contract (with possibility of the patient should start Perimesencephalic Subarachnoid Hemorrhage each month in the same day, so that Ductal Carcinoma in situ 20 -day intervals between courses of treatment), with g disease: 1 kaps. target year of drug: leukopenia and secondary immunodeficiency, particularly in chemotherapy and radiotherapy of cancer patients Rheumatoid Factor leukemia target year to reduce the toxic effects of cytostatics; surgical treatment of cancer, and G hr. Dysgalactiae, Enterococcus faecium, Enterococcus faecalis, as Mr intranasal introduction of aerosol packaging; lysis m / s is based on the original biological methods, which lets you nepatohenni and agricultural preserve specific properties of each strain, thus able to cause lysate in the mucosa of protective immune responses target year identical to the reactions of derivatives of infectious agents: imunokompstsntnyh stimulation and proliferation of cells, raising the level of lysozyme and interferon in secret, increasing the number of local and / t, especially Ig A, increased phagocytic activity, which contributes to elimination of infectious agents from the body. Infectious diseases of upper respiratory tract and VDSH: City and XP. Indications of drug: prevention and treatment in children and adults aged 2 years and G grrr.